Lifeward director granted 7,657 share RSU award

Reznick Yehuda reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Reznick Yehuda reported acquisition or exercise transactions in this Form 4 filing.

Lifeward Ltd. director Yehuda Reznick reported an equity compensation grant rather than a market trade. He received 7,657 ordinary shares in the form of restricted stock units granted on March 25, 2026 under the 2025 Incentive Compensation Plan. These RSUs vest in four equal quarterly installments starting three months after the grant date, and his direct holdings following the grant total 7,657 shares.

Insider Trade Summary

Grant/Award: 7,657 shares

Grant/Award 1 txn

Insider Reznick Yehuda

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares, no par value per share	7,657	$0.00	$0.00

Holdings After Transaction: Ordinary Shares, no par value per share — 7,657 shares (Direct)

Footnotes (1)

1. F1. Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Lifeward (LFWD) director Yehuda Reznick report in this Form 4?

He reported an equity compensation grant of 7,657 ordinary shares via restricted stock units. These RSUs were granted on March 25, 2026, under Lifeward’s 2025 Incentive Compensation Plan and represent his entire direct holding reported after this transaction.

Is the Lifeward (LFWD) Form 4 a stock purchase or a compensation award?

It is a compensation award, not an open-market purchase. The filing shows a grant of 7,657 restricted stock units with a transaction price of $0.00 per share, indicating shares were awarded as part of Lifeward’s 2025 Incentive Compensation Plan rather than bought in the market.

What is the vesting schedule for the 7,657 Lifeward RSUs granted to Yehuda Reznick?

The 7,657 restricted stock units vest ratably in four equal quarterly installments. Vesting starts three months after the March 25, 2026 grant date, meaning the award vests over roughly one year in four scheduled quarterly tranches, subject to the plan’s terms.

How many Lifeward shares does Yehuda Reznick hold after this Form 4 transaction?

After this transaction, he is reported as directly holding 7,657 ordinary shares. These reflect the restricted stock units granted on March 25, 2026, which are issuable as they vest over four quarterly installments starting three months after the grant date.

Does the Lifeward Form 4 indicate any stock sales or disposals by Yehuda Reznick?

No stock sales or disposals are reported. The Form 4 shows one acquisition transaction coded as a grant or award of 7,657 restricted stock units, with no corresponding sale, gift, tax withholding, or restructuring entries disclosed in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 04:56 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reznick Yehuda

(Last) (First) (Middle)

C/O LIFEWARD LTD.

2 CABOT RD.

(Street)

HUDSON MASSACHUSETTS 01749

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares, no par value per share	03/25/2026		A		7,657(1)	A	$0.00	7,657	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

	/s/ Almog Adar, as Attorney-in-Fact for Yehuda Reznik.	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)